Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Two ...

Alzheimer’s disease affects nearly 7 million Americans, a number that’s expected to jump to 13.9 million by 2060. Given the devastating effects of this incurable disease, the hunt is on for ...

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the ...

A Medicare analysis found large disparities in which Alzheimer's patients were treated with lecanemab. Lecanemab use was higher in people who were male, white, urban, and socioeconomically advantaged.

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s disease, the first diagnostic tool that uses a blood draw to check for ...